Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - ULTRALIFE CORP | a6819008ex99_1.htm |
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
Current Report
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of
earliest event reported):
August
4, 2011
ULTRALIFE
CORPORATION
(Exact name of registrant as specified in its
charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
|
0-20852 |
16-1387013 |
| (Commission File Number) | (I.R.S. Employer Identification No.) |
2000 Technology Parkway, Newark, New York 14513
(Address
of principal executive offices) (Zip Code)
(315)
332-7100
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02. |
Results of Operations and Financial Condition. |
Ultralife Corporation (NASDAQ: ULBI) reported operating income from continuing operations of $2.9 million on revenue of $43.6 million for the quarter ended July 3, 2011. For the second quarter of 2010, the company reported operating income from continuing operations of $1.0 million on revenue of $33.6 million.
The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed to be incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.
|
Item 9.01. |
Financial Statements, Pro Forma Financials and Exhibits. |
|
(a) |
Exhibits. |
|
99.1 Press Release dated August 4, 2011. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ULTRALIFE CORPORATION |
||||
|
Dated: |
August 4, 2011 |
By: |
|
/s/ Philip A. Fain |
|
|
Philip A. Fain |
|||
|
|
Chief Financial Officer & Treasurer |
|||
INDEX TO EXHIBITS
|
(99) |
Additional Exhibits |
|
|
99.1 Press Release dated August 4, 2011. |
||
3